Faculty

Clinical Research Division

Faculty

Search Clinical Faculty

Find a Lab or Project

Alphabetical Listing:

Select a letter to display a list of Faculty members
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  [Show All]
Assistant Member, Clinical Research Division
Research Assistant Professor of Medical Oncology, University of Washington School of Medicine
Retrovirus-based gene transfer into hematopoietic stem cells has emerged as a viable treatment for genetic, malignant and infectious diseases with the potential to significantly decrease global disease burden.
Phone: (206) 667-7110
Fax: (206) 667-6124
Executive Vice President and Deputy Director, External Affairs, Fred Hutchinson Cancer Research Center
Professor, Division of Medical Oncology, University of Washington
Phone: (206) 667-4412
Fax: (206) 667-6936
Assistant Member, Clinical Research Division
Associate Professor, Medical Oncology, University of Washington
Attending Physician, Thoracic, Head and Neck Medical Oncology, Seattle Cancer Care Alliance
Treatment of patients with thoracic, head and neck malignancies
Phone: (206) 606-6680
Fax: (206) 606-1435
Professor, Department of Pediatrics, University of Washington
Attending Physician, Pediatric Hematology/Oncology and Bone Marrow Transplantation, Seattle Children's Hospital
Acute and long term-effects of hematopoietic cell transplantation and the conduct of clinical trials in hematopoietic cell transplantation for non-malignant hematologic diseases
Phone: (206) 667-5594
Fax: (206) 667-5899
Assistant Member, Clinician Scholar Pathway, Clinical Research Division
Clinical Assistant Professor, Medical Oncology Division, Department of Medicine, University of Washington
Clinical and research focus on improving outcome of hematopoietic cell transplantation (HCT). Allogeneic HCT has the potential to provide long-term survival and even cure in patients with hematological malignancies.
Phone: (206) 667-4971
Fax: (206) 667-4937
Professor of Medicine, University of Washington
Member, Fred Hutch, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Research is focused on optimizing therapy of hematological malignancies, gene therapy for inherited stem cell disorders and clinical trials in acute myeloid leukemia and multiple myeloma.
Phone: (206) 616-1589
Fax: (206) 606-6356
Member, Head, Pediatric Oncology Program, Clinical Research Division
Head, Hematology Oncology Division, Seattle Children's Hospital
Research interests include blood-forming (hematopoietic) stem cells, antibody-targeted therapies for lymphoma and leukemia, and the biology of acute myeloid leukemia (AML).
Phone: (206) 667-1212
Fax: (206) 667-6084
Associate Member, Clinical Research Division
Gerdin Family Endowed Chair for Leukemia Research, Fred Hutchinson Cancer Research Center
Program Director, Transplantation Pediatric Leukemia , Clinical Research Division
Director, Cellular Therapy and Transplantation for Pediatric Leukemia, Clinical Research Division
Associate Professor, Pediatrics, University of Washington School of Medicine
Laboratory studies are focused on preventing graft-versus-host-disease for children undergoing allogeneic stem cell transplants, the discovery of leukemia associated minor histocompatibility antigens and the development of adoptive T cell immunotherapy.
Phone: (206) 667-6572
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Associate Professor of Pediatrics, University of Washington
Research focus includes Primary Immune Deficiency Treatment Consortium, Project 3, and allogeneic HCT for patients with nonmalignant inherited disorders using a treosulfan based preparative regimen
Phone: (206) 667-2396
Fax: (206) 667-5899
Department of Pediatrics, University of Washington
Clinical Director Pediatric Blood and Marrow Transplant Program, Seattle Cancer Care Alliance
Research focus is on acute and chronic graft-vs.-host disease (GVHD), the amelioration of long-term complications associated with GVHD therapies, and the prevention of relapse after transplant in the context of continued immunosuppressive therapy.
Phone: (206) 667-5191
Fax: (206) 667-1034
Assistant Member, Clinical Research Division
Developing novel therapies and risk-stratification methods for adults with acute lymphoblastic leukemia. Radioimmunotherapy-based conditioning regimens for hematopoietic cell transplantation in adults with high-risk lymphoma.
Phone: (206) 606-1202
Fax: (206) 606-1130
Assistant Member, Clinical Research Division
Assistant Professor, Department of Medicine, Division of Medical Oncology, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Research is centered on 1) understanding the factors associated with successful adoptive transfer of immune T cells and improving the outcomes of both native and gene-modified T cells targeting viral and tumor antigens, 2) developing methods that improve the survival, proliferation and anti-tumor activity of infused T-cell products so as to better eliminate tumor targets and 3) clinical strategies to modulate the host immune environment as a means to optimally activate T cells in humans.
Phone: (206) 667-4369
Fax: (206) 667-7983
Professor of Medicine/Oncology, University of Washington
Immunotherapy cancer vaccines and solid tumor research
Phone: (206) 667-4141
Fax: (206) 667-6366
Associate Member, Clinical Research Division
Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Washington
Attending Physician, Pulmonary / Critical Care Medicine, Seattle Cancer Care Alliance (SCCA)
Pulmonologist and critical care specialist who sees patients with pulmonary complications after hematopoietic stem cell transplantation (HCT), including infectious pneumonia and non-infectious pulmonary complications.
Phone: (206) 667-7074
Fax: (206) 667-5765
Assistant Member, Clinical Research Division
Novel therapeutics in prostate and bladder cancer, correlative science/translational studies in clinical trials , clinical and molecular predictors of response to cancer therapies and circulating microRNA biomarkers for prostate cancer.
Phone: (206) 606-1406
Fax: (206) 606-2042
Associate Member, Clinical Research Division
Associate Professor of Medicine, University of Washington
Clinical and translational research of gastrointestinal and pancreatic cancers, phase I experimental therapeutics and biomarker discovery.
Phone: (206) 606-6248
Fax: (206) 606-2042
Associate Member, Clinical Research Division
Associate Professor, Pediatrics, University of Washington
Medical Director, Cancer Survivorship Program, Seattle Children's Hospital
Late effects related to pediatric cancer and blood disorder therapy.
Phone: (206) 667-6930
Fax: (206) 667-5948
Executive Vice President and Deputy Director, Fred Hutchinson Cancer Research Center
Professor, Department of Medicine, University of Washington
Rosput Reynolds Endowed Chair, Fred Hutchinson Cancer Research Center
The Clurman Lab studies how cell division is regulated in normal cells, and how abnormal control of cell division leads to cancer. They hope to use these mechanistic insights into tumor formation to develop new cancer treatment strategies.
Phone: (206) 667-4524
Fax: (206) 667-5255
Assistant Professor, Division of Oncology, University of Washington
Assistant Member, Clinical Research Division
Focus is on colorectal, pancreas and liver cancers and other gastrointestinal malignancies. Research includes the assessment of genes affecting the progression of cancer, identifying new biomarkers, and the characterization of colorectal cancer Type X.
Phone: (206) 606-6658
Fax: (206) 606-2042
Associate Member, Clinical Research Division
Translational research focused on melanoma, non-melanoma skin cancers and sarcomas. Investigating anti-neoplastic agents in pre-clinical models, both alone and in combination with conventional chemotherapy agents, and working to understand the molecular basis of drug efficacy.
Phone: (206) 606-7439
Assistant Member, Clinical Research Division
Assistant Professor, Pediatric Hematology/Oncology, University of Washington
Pediatric stem cell transplant with focus on cord blood transplant and leukemia. Ex-vivo expansion of cord blood progenitor cells for clinical application and supportive care
Phone: (206) 667-1959
Fax: (206) 667-2324
Senior Vice President, Director and Full Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
President and Executive Director, Seattle Cancer Care Alliance
Head, Department of Medicine, Division of Medical Oncology, University of Washington
Past President, 2016-2017, American Association for Cancer Research
Past President, 2007-2008, American Society Clinical Oncology
Nancy Davidson is the vice president and director of Fred Hutch's Clinical Research Division and President and Executive Director of the Seattle Cancer Care alliance.
Professor of Medicine, University of Washington
Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair , Fred Hutchinson Cancer Research Center
Phone: (206) 667-5985
Fax: (206) 667-6124
Director, Program in Cord Blood Transplantation, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Associate Professor, Pediatric Hematology/Oncology, University of Washington
Madeline Dabney Adams Endowed Chair in AML Research, Clinical Research Division
The primary focus of the Delaney Lab is the development and clinical translation of methodologies for the ex vivo expansion of hematopoietic stem and progenitor cells. In particular, we have focused on methods for the ex vivo expansion of cord blood stem and progenitor cells with the goal of improving outcomes for patients undergoing cord blood transplantation.
Phone: (206) 667-1385
Fax: (206) 667-2324
Assistant Member, Clinical Research Division
Gastroenterologist, Seattle Cancer Care Alliance
Research focus: gut microbiome, metagenomics, bile acid metabolism, motility, gastrointestinal cancers. Clinical focus: inflammatory bowel disease, gastrointestinal cancers.
Phone: (206) 667-6649
Assistant Member, Program in Immunology, Clinical Research Division
Understanding the mechanisms underlying endogenous (natural) thymic regeneration so that new therapies might be developed to enhance T-cell immunity, as needed.
Phone: (206) 667-3204
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Clinical Director, Thoracic/Head & Neck Oncology, Seattle Cancer Care Alliance
Medical Director, Quality, Safety and Value, Seattle Cancer Care Alliance
Phone: (206) 606-6249
Fax: (206) 606-1435
Assistant Member, Clinical Research Division
Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine
Clinical focus is diagnosis and management of benign and malignant hematologic disorders as well as solid tumors. Research includes developing immune-based approaches to prevent and treat relapse of myeloid cancers, including after allogeneic HSCT.
Phone: (206) 667-4082
Fax: (206) 667-2917
Professor, Pathology, University of Washington
Director, Cytogentics, Seattle Cancer Care Alliance
Director, Division of Cytogenetics and Genomics, University of Washington
Adjunct Professor, Laboratory Medicine, University of Washington
Identifying genetic and epigenetic aberrations in cancer that are prognostically significant and may serve as actionable biomarkers for treatment decision making for individual patients
Phone: (206) 606-1385
Fax: (206) 606-7567
Department of Medicine, University of Washington
Medical Director, Long-Term Follow-Up Clinic, Seattle Cancer Care Alliance
Management of chronic GVHD and other late effects of hematopoietic cell transplantation. Donor lymphocytes infusion for treatment of recurrence malignancies after allogeneic stem cell transplantation.
Phone: (206) 667-5160
Fax: (206) 667-1034
Associate Member, Clinical Research Division
Phone: (206) 667-5077
Fax: (206) 606-2054
Associate Member, Clinical Research Division
Associate Professor of Medicine, University of Washington
Hematopoietic cell transplantation for severe autoimmune diseases, nonmyeloablative hematopoietic cell transplantation, hematopoietic stem cell and T cell gene therapy and the development of radiation mitigators
Phone: (206) 667-6886
Fax: (206) 667-6124
President and CEO, Scisco Genetics Inc.
The Geraghty laboratory is interested in the genetics of the immune response and the consequential functions of key components. We are examining the essential detail of the genetics and genomics of the immune response in humans and nonhuman primates, detail that differs among individuals and directly affects a plethora of immune interactions and derivative clinical outcomes.
Phone: (206) 667-4668
Fax: (206) 667-6948
Affiliate Associate Professor, Department of Biostatistics, University of Washington
Research is focused on the design and analysis of laboratory research, clinical trials and observational studies in hematopoietic cell transplant (HCT), and in rheumatology, breast cancer, ovarian cancer, as well as a wide variety of large laboratory projects at Fred Hutch and throughout the world.
Phone: (206) 667-6533
Fax: (206) 667-6358
Associate Professor, Medical Oncology Division, University of Washington School of Medicine
Director of Clinical Research, Hematology Malignancies/Hematology, Seattle Cancer Care Alliance
Developing novel targeted therapies for lymphomas with particular emphasis on radioimmunotherapy-based transplant conditioning regimens, low toxicity proapoptotic agents for indolent lymphomas, and safe curative regimens for older adults with lymphoma.
Phone: (206) 667-6533
Fax: (206) 667-6358
Assistant Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Molecular profiling and early detection for lung cancer
Phone: (206) 667-2778
Fax: (206) 667-5977
Rodger C. Haggitt Professor, Division of Gastroenterology, University of Washington School of Medicine
Medical Director, GI Cancer Prevention Program Clinic, Seattle Cancer Care Alliance
Molecular and cell biology of gastrointestinal cancer; genetic and epigenetic alterations in cancer.
Phone: (206) 667-1107
Fax: (206) 667-2917
Associate Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Laboratory and clinical research is focused on developing new immunotherapeutic approaches to treat and ultimately eradicate multiple myeloma and lymphoma.
Phone: (206) 667-5398
Fax: (206) 667-1874
Member & Head, Program in Immunology, Clinical Research Division
Professor of Medicine & Immunotherapy, University of Washington
Basic immunology and cancer immunobiology, and on the development and assessment of adoptive therapies with antigen-specific T cells targeting human malignancies and chronic infections.
Phone: (206) 667-7791
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Research is focused on the development, invasion and metastasis of intestinal cancers characterized by chromosome/genetic instability and dysregulated proliferation. Treats patients with cancers of the lung, rectum, small intestines or colon, as well as patients with myeloma and non-Hodgkin's lymphoma.
Phone: (206) 667-7994
Assistant Member, Pediatric Oncology and Stem Cell and Gene Therapy Programs, Integrated Immunotherapy Research Center, Clinical Research Division
Research is focused on understanding the factors that control the formation of the hematopoietic stem cells, harnessing technologies to analyze gene activities across the many different cell types within the special hematopoietic stem cell niche and identifying specific biological signals that trigger the formation of blood stem cells to develop a system for generating and cultivating blood stem cells in the lab.
Phone: (206) 667-1095
Fax: (206) 667-6084
Member Emeritus , Clinical Research Division
Professor, Medical Oncology Division, University of Washington School of Medicine
Medical Director, Clinical Immunogenetics Laboratory, Seattle Cancer Care Alliance
Attending Physician, Seattle Cancer Care Alliance
Management of Bone Marrow Transplant Patients, Donor Selection, Immune Suppression Therapy, Graft-versus-Host Disease, Biology of the Human MHC and Transplantation Tolerance.
Phone: (209) 667-5111
Fax: (209) 667-5255
Associate Member, Clinical Research Division
Involved in several ongoing investigations of new therapeutics for the treatment of gastrointestinal malignancies. Main current focus of investigation involves the study of new drugs such as targeted therapy and/or immunotherapy, the study of novel combinations of drugs, or local interventions in combination with experimental drug therapies for the treatment of hepatocellular carcinoma and biliary tract cancers (including cholangiocarcinoma).
Phone: (206) 606-6856
Fax: (206) 606-2042
Assistant Member, Clinical Research Division
Studies the cellular and molecular dynamics that underlie metastasis, i.e. the spread of cancer cells from a primary tumor to distant organs. The main focus of his lab is the tumor-immune cell interactions that variably promote or defend against metastasis, particularly in lung cancers.
Phone: (206) 667-3619
Fax: (206) 667-2917
Professor, Department of Medicine and Urology, University of Washington
Phone: (206) 606-1152
Fax: (206) 606-2042
Director of Hematopoietic Stem Cell Transplantation, Fred Hutch/Seattle Cancer Care Alliance
Full Professor, Division of Medical Oncology, University of Washington
José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research, Fred Hutchinson Cancer Research Center
Research and clinical practice involving hematopoietic stem cell transplantation and cancer immunotherapy. Studies address the graft-vs-host disease, opportunistic infection, relapse and graft rejection.
Assistant Member, Clinical Research Division
Attending Physician, SCCA Infectious Disease Service , Seattle Cancer Care Alliance
Assistant Professor, University of Washington
Clinical and translational investigations relating to infections in immunocompromised hosts, with a focus on disease associations, risk stratification, and diagnostic strategies for viral infections in transplant recipients
Phone: (206) 667-6504
Fax: (206) 667-4411
Professor, Medicine, University of Washington
Director, Center for Accelerated Translation in Pancreas Cancer (CATPAC), Seattle Translational Tumor Research
Raisbeck Endowed Chair for Pancreatic Research, Clinical Research Division
The molecular and cellular mechanisms that drive the pathogenesis of pancreas cancer
Phone: (206) 667-6921
The Hockenbery lab studies programmed cell death (apoptosis) pathways that are defective in many cancer cells; and the role of cancer-cell metabolism in apoptosis, oncogene functions, and environmental/dietary risk factors, including excess supply of nutrients. After identifying cancer-selective targets, they carry out small-molecule screens for inhibitors to identify lead compounds as anticancer agents.
Phone: (206) 667-4611
Fax: (206) 667-6519
Associate Professor, Department of Medicine and Oncology, University of Washington
Research is focused on trying to augment the immune system after an autologous transplant. A number of clinical trials using different approaches have been developed.
Phone: (206) 667-6447
Fax: (206) 667-4937
Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Washington
The initial focus was to study the role of inflammatory cell derived proteinases in diseases occurring within the lungs. To date, this has included novel findings for many disease processes including lung cancer, COPD/emphysema, acute lung injury, pulmonary infections, and pulmonary fibrosis. More recently, the focus has shifted to the tumor microenvironment.
Phone: (206) 667-3175
Fax: (206) 667-5255
Associate Member, Clinical Research Division
Acting Assistant Professor, Department of Pathology, University of Washington
Hematopathologist/Surgical Pathologist, Seattle Cancer Care Alliance
Hematolymphoid neoplasms and bone marrow transplant pathology
Phone: (206) 606-7083
Fax: (206) 606-1345
Assistant Member, Gastroenterology & Hepatology, Clinical Research Division
Assistant Professor, Department of Internal Medicine; Division of Gastroenterology, University of Washington School of Medicine
Assistant Member, Hutchinson Institute for Cancer Outcomes Research (HICOR), Public Health Sciences Division
Understanding patient barriers and facilitators to colorectal cancer screening, determining factors that influence colonoscopy completion following abnormal stool-based screening tools and identifying gaps in care to implement interventions that improve the quality of cancer control and prevention, particularly in minority populations.
Phone: (206) 667-1447
Fax: (206) 667-5977
Associate Professor, Department of Pediatrics, University of Washington
Director of the Ben Town Center for Childhood Cancer Research, University of Washington
The Kean lab is working to solve the mystery of immune recognition and immune tolerance
Phone: (206) 884-4079
Fax: (206) 667-6939
Endowed Chair for Cell and Gene Therapy, Clinical Research Division
Director, Stem Cell and Gene Therapy Program, Clinical Research Division
Associate Head of Transplantation Biology, Clinical Research Division
The Kiem Lab is focused on research and clinical trials using stem cell biology and stem cell gene transfer with the goal of developing stem cell-based treatment strategies for patients with genetic or infectious stem cells. We are conducting studies using embryonic stem cells and induced pluripotent stem cells.
Phone: (206) 667-4409
Fax: (206) 667-6124
Assistant Member, Clinical Research Division
Bone marrow transplantation for patients with cancers like acute myeloid leukemia and lymphoma and the development of safe and effective immunotherapy approaches using unrelated donors.
Phone: (206) 667-3410
Fax: (206) 667-6124
Member, Associate Director, Clinical Research Division
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutchinson Cancer Research Center
Clinical expertise is hematology providing hematopoietic cell transplants to patients with blood disorders. Her research is focused on survivorship issues, quality-of-life and the impact of chronic graft-versus-host-disease.
Phone: (206) 667-6190
Fax: (206) 667-1034
Assistant Member, Clinical Research Division
Tumor infiltrating lymphocyte therapy for melanoma, bladder and head and neck cancers
Phone: (206) 606-2274
Fax: (206) 606-1435
Affiliate Professor of Biostatistics, University of Washington
Survivorship after cancer, clinical research related to stem cell transplantation, and statistical methodology for studies of diagnostic tests.
Phone: (206) 667-4374
Fax: (206) 667-6358
Associate Professor, Division of Medical Oncology, University of Washington
Associate Member, Clinical Research Division
Medical Oncologists, Hematologic Malignancies, Seattle Cancer Care Alliance
Clinical and research focus includes multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis and lymphoma.
Phone: (206) 606-1453
Fax: (206) 606-6356
A breast cancer specialist active in clinical and translational research including estrogen receptor targeted therapies.
Phone: (206) 606-2053
Fax: (206) 606-2023
Medical Director, Apheresis, Seattle Cancer Care Alliance
Clinical and research focus includes anemia, bleeding and thrombotic disorders, sickle cell disease, myeloma, leukemia, and other hematologic disorders.
Phone: (206) 667-5021
Fax: (206) 667-5899
Associate Member, Clinical Research Division
Clinical focus is bone marrow transplant pathology including accessing hematologic malignancy, graft-vs-host disease and infection in stem cell transplant patients.
Phone: (206) 606-1356
Fax: (206) 606-1345
Associate Member, Clinical Research Division
Assistant Clinical Professor of Medicine, University of Washington
Medical Director, Supportive and Palliative Care, Seattle Cancer Care Alliance (SCCA)
Treats patients with sarcoma, a rare cancer of the bones and soft tissue, with a focus on GIST (gastrointestinal stromal tumor), intra-abdominal and retroperitoneal tumors and rare, aggressive forms of sarcoma.
Phone: (206) 667-7442
Fax: (206) 667-6936
Member/Section Head for Pulmonary and Criticare Medicine, Clinical Research Division
Associate Professor, Division of Pulmonary and Critical Care Medicine, University of Washington
Clinical focus is on early lung cancer diagnosis and staging and research focus is on mesenchymal cell therapy for radiation induce lung injury and pneumonia syndrome after stem cell transplantation
Phone: (206) 667-4589
Fax: (206) 667-5765
Assistant Member, Clinical Research Division
Assistant Professor, Pediatric Hematology/Oncology, University of Washington
Improving outcomes for pediatric patients with non-malignant disorders who undergo hematopoietic stem cell transplantation
Phone: (206) 667-2014
Fax: (206) 667-5899
Medical Director, Cellular Immunotherapy, Immunotherapy
Leonard and Norma Klorfine Endowed Chair for Clinical Research, Fred Hutchinson Cancer Research Center
Service Medical Director, Cellular Immunotherapy, Bezos Family Immunotherapy Clinic, Seattle Cancer Care Alliance
Professor of Medicine, Division of Oncology, University of Washington
Improving treatments for patients with CLL, lymphoma and myeloma by increasing activity and decreasing toxicity
Phone: (206) 667-5616
Fax: (206) 667-6124
Member, Division of Clinical Research, Fred Hutchinson Cancer Research Center
Professor, Medical Oncology Division, University of Washington
Medical Director, Clinical Research Support, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Phone: (206) 667-4798
Fax: (206) 667-5255
Associate Medical Director, Adult Solid Tumor Oncology, Seattle Cancer Care Alliance
Clinical Research Director, Thoracic and Head and Neck Oncology, Seattle Cancer Care Alliance
Full Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
Professor of Medicine, University of Washington
Stephen H. Petersdorf Endowed Chair in Cancer Care, University of Washington
Research is focused immunotherapy, targeted therapies and the design of clinical trials for head and neck and lung cancers
Phone: (206) 606-6723
Fax: (206) 606-1435
Member Emeritus, Gastroenterology / Hepatology Section, Clinical Research Division
Professor, Department of Medicine, Division of Gastroenterology, University of Washington School of Medicine
Prevention, diagnosis, and treatment of gastrointestinal and hepatobiliary problems in patients undergoing hematopoietic cell transplantation
Phone: (206) 667-6932
Full Faculty Member, Clinical Research Division
Professor, Division of Pediatric Hematology/Oncology, Seattle Children's Hospital
Professor, Division of Pediatric Hematology/Oncology, University of Washington
Attending Physician, Pediatric Hematology Oncology Specialist, Seattle Children's Hospital
Attending Physician, Pediatric Hematology Oncology Specialist, Seattle Cancer Care Alliance (SCCA)
Stem cell transplantation for pediatric leukemia patients, management of post-transplant relapse and targeted therapies for acute myeloid leukemia patients.
Phone: (206) 667-4077
Fax: (206) 667-4310
Professor, Department of Medicine, University of Washington
Medical Director, Adult Blood and Marrow Transplantation, Fred Hutch and Seattle Cancer Care Alliance
Blood and bone marrow stem cell transplantation for hematologic cancers. Graft-versus-host disease (GVHD).
Phone: (206) 667-2827
Fax: (206) 667-6124
Assistant Member, Clinical Research Division
Associate Director Cord Blood Transplantation, Cord Blood Program
Assistant Professor, University of Washington
Research is focused on the use of umbilical cord blood transplantation as source of stem cells
Phone: (206) 667-5925
Fax: (206) 667-2324
Associate Member, Clinical Research Division
Associate Professor, Medical Oncology Division, University of Washington School of Medicine
Attending Physician, Seattle Cancer Care Alliance
Research is focused on androgen and androgen receptor-related mechanisms of resistance that lead to prostate cancer progression. Current areas of research include pathways of intra-tumoral androgen steroidogenesis and metabolism, structural alterations in the androgen receptor, the activity of androgen transport proteins, and how alterations in these and other pathway may influence the sequencing of androgen and chemotherapy treatments. An important goal is to determine how patient and tumor-specific alterations in these proteins may be used to predict response to agents targeting these pathways.
Phone: (206) 667-3506
Fax: (206) 667-5456
Professor of Medicine, Rheumatology, University of Washington
Affiliate Professor, Department of Genome Sciences, University of Washington
Immunologic consequences of maternal-fetal exchange during pregnancy and the legacy that maternal-fetal exchange creates for both individuals years later
Phone: (206) 667-6840
Fax: (206) 667-5255
Associate Member, Clinical Research Division
Associate Professor of Medicine, Division of Hematology, University of Washington School of Medicine
Clinical and research focuses on the mechanisms of leukemic disease progression and therapy resistance, new agents in the treatment of chronic myeloid leukemia (CML) and acute myeloid leukemia (AML)
Phone: (206) 667-1340
Fax: (206) 667-2917
Assistant Member, Clinical Research Division
Assistant Professor, Department of Medicine, Division of Hematology, University of Washington
Hematologic malignancies, including leukemias and lymphomas, and tailoring treatment plans to deliver high quality care. Developing radioimmunotherapies that use immune system proteins known as antibodies to selectively target radioactivity to cancer cells, sparing normal tissues.
Phone: (206) 667-4102
Fax: (206) 667-1854
Director, Early Detection Initiative, Fred Hutchinson Cancer Research Center
Aven Foundation Endowed Chair, Fred Hutchinson Cancer Research Center
Professor, Department of Medicine/Division of Oncology, University of Washington
Associate Faculty Member, Molecular and Cellular Biology Program, University of Washington
Technologies and strategies for translation of novel diagnostics and therapeutics to enable precision medicine
Phone: (206) 667-1912
Fax: (206) 667-2277
Assistant Professor, Division of Hematology, University of Washington School of Medicine
Assistant Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Develops early-phase clinical trials for patients with AML, specifically testing new drugs and new combinations of drugs.
Phone: (206) 606-1320
Fax: (206) 606-1130
Professor of Medicine, Medical Oncology Division, University of Washington School of Medicine
Studies how genetic factors influence the success of transplants, including how to optimize the matching of patients with unrelated donors.
Phone: (206) 667-5244
Fax: (206) 667-5255
Member, Program in Immunology, Clinical Research Division
Scientific Director, Immunopathology Lab, Clinical Research Division
Mechanisms of tumor-induced immune tolerance by which tumors can escape anti-tumor immune responses, including natural and therapy-induced responses
Phone: (206) 667-6648
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Assistant Professor, Division of Oncology, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Develops new ways to enhance the immune response against sarcomas.
Phone: (206) 667-6629
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Associate Member, Biostatistics Porgram, Public Health Sciences Division
Research focus: Methods for the analysis of high-dimensional, longitudinal and functional data, including array, spectral, image and network-based data.
Phone: (206) 667-1079
Fax: (206) 667-7004
Associate Member, Clinical Research Division
Lead Statistician, Lung Map Trial
Research focus is on biostatistics, clinical trial design incorporating biomarkers and lung cancer.
Phone: (206) 667-4767
Fax: (206) 667-6358
Professor, Department of Radiation Oncology, University of Washington School of Medicine
Associate Member, Clinical Research Division
Medical Director, SCCA Proton Therapy Center, Seattle Cancer Care Alliance
Research is focused on photon- and proton-based regimens to trigger an immune response to augment immunotherapies in solid tumors.
Phone: (206) 306-2814
Fax: (206) 417-0347
Member, Clinical Research Division, Program in Immunology, Program in Immunology
Professor, School of Medicine, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Studies focus on 1) understanding the roles of distinct T cell subsets in protective immunity to pathogens and tumors and on 2) the development and clinical application of adoptive T cell therapies for viral diseases and cancers, using unmodified and genetically modified antigen-specific T cells.
Phone: (206) 667-7791
Fax: (206) 667-7983
Associate Member, Clinical Research Division
Associate Professor, University of Washington School of Medicine, Department of Medicine, Division of Medical Oncology
Hematologist/Oncologist, Seattle Cancer Care Alliance
Squamous cell cancers of the head and neck, salivary gland malignancies, thyroid cancer, lung cancer
Phone: (206) 606-2048
Assistant Member, Program in Immunology, Clinical Research Division
Studies the very first steps that lead to a productive immune response. These involve circulating “innate” immune cells that initially recognize problems, such as cells infected by a virus or transformed by malignant changes.
Phone: (206) 667-7753
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Improving long-term outcomes for cord blood transplant recipients and treating adult patients with hematologic malignancies who have had an autologous or allogeneic stem cell transplant.
Phone: (206) 667-1317
Fax: (206) 667-2324
Phone: (206) 667-4348
Fax: (206) 667-5899
Professor of Medicine, University of Washington
Stem cell engraftment in MHC-matched and mismatched transplants: development of nonmyeloablative conditioning regimens
Phone: (206) 667-4961
Fax: (206) 667-6124
Assistant Member, Clinical Research Division
Attending Physician , Seattle Cancer Care Alliance
Medical Director, Infusion and Pharmacy Services, Seattle Cancer Care Alliance
Research interests include health services research, where main goal is to understand how patients are treated in the general population (who do not have access to cancer centers) and learning how the most recent advances might be brought to treating these individuals. Also working to design and implement clinical trials that might establish a new, life-saving treatment. Another recent focus is on strategies to harness the immune system in treating virus-associated cancers. Medical oncologist who is board certified in Internal Medicine and in Hematology/Oncology. Specializes in treating patients with lung and head-and-neck cancers, and also has experience in treating patients with breast, gastric and hematologic cancers.
Phone: (206) 606-2190
Fax: (206) 606-1435
Assistant Professor, Medicine, Oncology, University of Washington School of Medicine
Assistant Member, Clinical Research Division
Research focus is translational prostate cancer research and novel therapeutics/drug development. Clinical expertise is genitourinary oncology (Prostate, bladder, kidney and testicular cancers)
Phone: (206) 606-6252
Fax: (206) 606-2042
Associate Member, Transplantation Program, Clinical Research Division
Assistant Professor of Medicine, Division of Oncology, University of Washington
Director of Hematology and Hematologic Malignancies, Seattle Cancer Care Alliance
Clinical trials for myelodysplastic syndrome and myeloproliferative disorders
Phone: (206) 667-1990
Fax: (206) 667-6124
Assistant Member, Clinical Research Division
Assistant Professor, Medical Oncology Division, Department of Medicine, University of Washington
Attending Physician, Hematologic Malignancies, Seattle Cancer Care Alliance (SCCA)
Therapeutic clinical trials on chronic lymphocytic leukemia and small lymphocytic lymphoma, clinical outcomes in hematopoietic cell transplantation and the epidemiology of hematologic malignancies
Phone: (206) 667-5467
Fax: (206) 667-1874
Associate Member, Clinical Research Division
Phone: (206) 667-7844
Assistant Member, Clinical Research Division
Assistant Professor of Medicine, University of Washington
Micro-environment control of hematopoietic stem cells, restoration of stem cell function in bone marrow failure and the development of therapeutic strategies to enhance post-transplant reconstitution
Associate Professor, University of Washington
Associate Member, Clinical Research Division
Medical Oncologist, Seattle Cancer Care Alliance
Developing novel, targeted therapies for the treatment of Non-hodgkin and Hodgkin lymphomas and identification of clinical and biologic prognostic factors in lymphoma
Phone: (206) 606-6546
Associate Member, Clinical Research Division
Associate Professor of Medicine, University of Washington
Outcome research in hematological malignancies to inform the decision-making process for treatment of these malignancies
Phone: (206) 667-6248
Fax: (206) 667-5899
Associate Member, Clinical Research Division
Associate Professor, Medical Oncology, University of Washington Medical Center
Breast cancer genetics, investigational breast cancer treatments
Phone: (206) 606-6889
Fax: (206) 606-2023
Associate Member, Clinical Research Division
Associate Professor of Medicine, University of Washington
Gastrointestinal cancer prevention, including genetic and clinical predisposition, chemoprevention, and early detection.
Phone: (206) 606-2275
Fax: (206) 667-5899
Associate Member, Program in Immunology, Clinical Research Division
Associate Professor, Department of Medicine, Division of Oncology, University of Washington School of Medicine
Adjunct Assistant Professor, Department of Bioengineering, University of Washington
Allen Distinguished Investigator , The Paul G. Allen Frontiers Group
Next-generation immunomodulatory synthetic materials, we are developing new approaches to therapeutically boost the body's natural ability to fight cancer
Phone: (206) 667-6677
Fax: (206) 667-7983
Medical Director and Vice President of the Seattle Cancer Care Alliance, where he oversees SCCA outpatient clinics, including clinical care and quality monitoring
Phone: (206) 606-1192
Fax: (206) 606-6643
The overall goals of my research are to identify novel biomarkers for hematopoietic malignancies and to understand how these biomarkers may function to promote the development of diseases.
Phone: (206) 667-5386
Fax: (206) 667-1809
Member and Head of Transplantation Biology Program, Clinical Research Division
Professor of Medicine, Oncology, University of Washington
The Program in Transplantation Biology combines basic and translational research directed at understanding and eliminating major barriers to successful allogeneic hematopoietic stem cell transplantation; these include host-versus-graft reactions, graft failure, acute and chronic graft-versus-host disease (GVHD), regimen-related toxicities, and induction of graft-versus-tumor reactions. The program’s goal has been to use stem cell transplantation to treat patients with malignant and nonmalignant hematologic diseases.
Phone: (206) 667-4407
Fax: (206) 667-6124
Biostatistical methods and applications in clinical trials and epidemiology
Phone: (206) 667-6151
Fax: (206) 667-6358
Assistant Member, Clinical Research Division
Assistant Professor, Pediatric Hematology/Oncology, University of Washington
The development of cellular therapy for leukemia. Specifically, the development of T-cell therapies that potentially prevent relapse of acute lymphoblastic leukemia in patients who received cord blood transplants.
Phone: (206) 667-3119
Fax: (206) 667-2324
Director, Behavioral Sciences, Clinical Research Division
Co-Director, Survivorship Program, Clinical Research Division
Determining acute, long term and late complications of cancer treatment for hematopoietic cell transplantation and other cancer survivors, along with clinical trials to improve outcomes during and after cancer treatment
Phone: (206) 667-4579
Fax: (206) 667-4356
Immunotherapy; activated lymphocytes and cytokines; melanoma; kidney cancer
Phone: (206) 606-2044
Email: jat@uw.edu
Fax: (206) 606-6210
Associate Member, Clinical Research Division
Associate Professor, Medicine, University of Washington
Attending Physician, Stem Cell Transplant Service, Seattle Cancer Care Alliance
New immunotherapies for lymphoma, focusing on the approach of adoptive T cell therapy with autologous T lymphocytes genetically engineered to express a chimeric antigen receptor (CAR).
Phone: (206) 667-7269
Fax: (206) 667-1874
Regulations of hematopoiesis, extrinsic control of stem cell fate and identification of regulatory components
Phone: (206) 667-4545
Fax: (206) 667-5978
Assistant Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Dr. Triplette has studied racial disparities in coronary artery disease, chronic lung disease in HIV patients, and community-based screening for HIV and lung cancer. His current collaborative studies focus on lung cancer screening practices in underserved and at-risk populations.
Phone: (206) 667-6335
Fax: (206) 667-5765
Associate Member, Clinical Research Division
Attending Physician, Seattle Cancer Care Alliance
Adoptive T cell therapy for hematologic malignancies and in investigating the immunologic perturbations in hematopoietic stem cell transplantation
Phone: (206) 667-7073
Fax: (206) 667-7983
Assistant Member, Clinical Research Division
Research is focused on the treatment and prevention of relapse after allogeneic transplant, nonmyeloablative conditioning regimens and the prevention of graft-vs-host disease
Phone: (206) 667-4546
Fax: (206) 667-6124
Assistant Member, Clinical Research Division
Assistant Professor, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Research focus is improving transplant outcomes through reduced intensity or nonmyeloablative conditioning regimens, and the prevention of graft-vs.-host disease.
Phone: (206) 667-2749
Fax: (206) 667-6124
Associate Member, Clinical Research Division
Associate Professor of Medicine, Division of Hematology, University of Washington School of Medicine
Adjunct Associate Professor, Department of Epidemiology, School of Public Health, University of Washington
Research is focused on the the preclinical and early clinical development and characterization of novel antigen-directed immunotherapies for AML, the conduct of trials testing novel treatments and innovative care approaches for AML patients, and approaches to develop and improve diagnostic and prognostic tools in AML.
Phone: (206) 667-3599
Fax: (206) 667-6519
Member, Program in Immunology, Clinical Research Division
Professor of Medicine, Department of Medicine, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Program Head, Global Oncology, Global Oncology
Clinical focus is treating patients with blood cancers such as leukemia, lymphoma, and multiple myeloma. Research is focused on cancer immunology, specifically the mechanisms and molecules that mediate graft-versus-host disease and graft-versus tumor.
Phone: (206) 667-6441
Fax: (206) 667-7983
Professor, Pediatrics, University of Washington
Director, Unrelated Donor Program, Seattle Cancer Care Alliance
Research interests include transplantation and HIV. Dr. Woolfrey is director of the unrelated donor program at Fred Hutchinson and SCCA.
Phone: (206) 667-4453
Fax: (206) 667-4937
Assistant Member, Clinical Research Division
Clinical trial design, modeling and statistical analyses of biomarkers, genetics and patient outcomes
Phone: (206) 667-3358
Fax: (206) 667-6358
Associate Member, Clinical Research Division
Assistant Professor, University of Washington
Molecular profiling of Myelodysplastic Syndromes and transplant pathology
Phone: (206) 606-7104
Fax: (206) 606-1345
Professor, Division of Gerontology, University of Washington School of Medicine
Mechanisms and adaptive cellular responses to ischemic and toxic kidney injury
Phone: (206) 667-6549
Fax: (206) 667-5255